Kezar Life Sciences Stock Today
| KZR Stock | USD 5.83 0.05 0.87% |
PerformanceVery Weak
| Odds Of DistressAverage
|
Kezar Life is selling at 5.83 as of the 20th of March 2025; that is 0.87 percent increase since the beginning of the trading day. The stock's lowest day price was 5.68. Kezar Life has over 55 % chance of experiencing financial distress in the next 2 years of operation and has generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company was incorporated in 2015 and is based in South San Francisco, California. The company has 7.3 M outstanding shares of which 120.6 K shares are now shorted by investors with about 1.46 days to cover. More on Kezar Life Sciences
Moving together with Kezar Stock
Moving against Kezar Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Kezar Stock Highlights
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Kezar Life Sciences (KZR) is traded on NASDAQ Exchange in USA. It is located in 4000 Shoreline Court, South San Francisco, CA, United States, 94080 and employs 58 people. Kezar Life is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a total capitalization of 42.54 M. Kezar Life Sciences runs under Biotechnology sector within Health Care industry. The entity has 7.3 M outstanding shares of which 120.6 K shares are now shorted by investors with about 1.46 days to cover.
Kezar Life Sciences has about 306.84 M in cash with (81.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.49.
Check Kezar Life Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Kezar Life Sciences is $42.54 Million. Over half of Kezar Life's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Kezar Ownership Details
Kezar Life Sciences Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Kezar Life market risk premium is the additional return an investor will receive from holding Kezar Life long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | 0.0724 | |||
| Treynor Ratio | (0.89) |
Kezar Stock Against Markets
Kezar Life Corporate Management
| Joe Tedrick | Vice Resources | Profile | |
| Noreen MD | Chief Officer | Profile | |
| Pattie Chiang | Senior Controller | Profile | |
| Michael Wolfe | Sr Operations | Profile |
Additional Tools for Kezar Stock Analysis
When running Kezar Life's price analysis, check to measure Kezar Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kezar Life is operating at the current time. Most of Kezar Life's value examination focuses on studying past and present price action to predict the probability of Kezar Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kezar Life's price. Additionally, you may evaluate how the addition of Kezar Life to your portfolios can decrease your overall portfolio volatility.